BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gieseke F, Schütt B, Viebahn S, Koscielniak E, Friedrich W, Handgretinger R, Müller I. Human multipotent mesenchymal stromal cells inhibit proliferation of PBMCs independently of IFNgammaR1 signaling and IDO expression. Blood. 2007;110:2197-2200. [PMID: 17522338 DOI: 10.1182/blood-2007-04-083162] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu L, Wang Y, Fan H, Zhao X, Liu D, Hu Y, Kidd AR, Bao J, Hou Y. MicroRNA-181a Regulates Local Immune Balance by Inhibiting Proliferation and Immunosuppressive Properties of Mesenchymal Stem Cells. STEM CELLS 2012;30:1756-70. [DOI: 10.1002/stem.1156] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 6.8] [Reference Citation Analysis]
2 Lohan P, Treacy O, Morcos M, Donohoe E, O'donoghue Y, Ryan AE, Elliman SJ, Ritter T, Griffin MD. Interspecies Incompatibilities Limit the Immunomodulatory Effect of Human Mesenchymal Stromal Cells in the Rat. Stem Cells. 2018;36:1210-1215. [PMID: 29726063 DOI: 10.1002/stem.2840] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
3 Bárcia RN, Santos JM, Filipe M, Teixeira M, Martins JP, Almeida J, Água-Doce A, Almeida SC, Varela A, Pohl S, Dittmar KE, Calado S, Simões SI, Gaspar MM, Cruz ME, Lindenmaier W, Graça L, Cruz H, Cruz PE. What Makes Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells Superior Immunomodulators When Compared to Bone Marrow Derived Mesenchymal Stromal Cells? Stem Cells Int 2015;2015:583984. [PMID: 26064137 DOI: 10.1155/2015/583984] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 6.7] [Reference Citation Analysis]
4 Arango-Rodriguez ML, Ezquer F, Ezquer M, Conget P. Could cancer and infection be adverse effects of mesenchymal stromal cell therapy? World J Stem Cells 2015; 7(2): 408-417 [PMID: 25815124 DOI: 10.4252/wjsc.v7.i2.408] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
5 Wang Y, Chen X, Cao W, Shi Y. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications. Nat Immunol. 2014;15:1009-1016. [PMID: 25329189 DOI: 10.1038/ni.3002] [Cited by in Crossref: 688] [Cited by in F6Publishing: 665] [Article Influence: 98.3] [Reference Citation Analysis]
6 Müller I, Lymperi S, Dazzi F. Mesenchymal stem cell therapy for degenerative inflammatory disorders. Current Opinion in Organ Transplantation 2008;13:639-44. [DOI: 10.1097/mot.0b013e328317a462] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
7 Larghero J, Vija L, Lecourt S, Michel L, Verrecchia F, Farge D. Cellules souches mésenchymateuses et immunomodulation : vers de nouvelles stratégies immunosuppressives pour le traitement des maladies auto-immunes ? La Revue de Médecine Interne 2009;30:287-99. [DOI: 10.1016/j.revmed.2008.08.019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wang H, Wu M, Liu Y. Are mesenchymal stem cells major sources of safe signals in immune system? Cellular Immunology 2012;272:112-6. [DOI: 10.1016/j.cellimm.2011.10.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
9 Muraro PA, Uccelli A. Immuno-therapeutic potential of haematopoietic and mesenchymal stem cell transplantation in MS. Results Probl Cell Differ 2010;51:237-57. [PMID: 19513637 DOI: 10.1007/400_2008_14] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
10 Sivanathan KN, Gronthos S, Rojas-Canales D, Thierry B, Coates PT. Interferon-gamma modification of mesenchymal stem cells: implications of autologous and allogeneic mesenchymal stem cell therapy in allotransplantation. Stem Cell Rev. 2014;10:351-375. [PMID: 24510581 DOI: 10.1007/s12015-014-9495-2] [Cited by in Crossref: 101] [Cited by in F6Publishing: 96] [Article Influence: 12.6] [Reference Citation Analysis]
11 Jones SP, Guillemin GJ, Brew BJ. The kynurenine pathway in stem cell biology. Int J Tryptophan Res 2013;6:57-66. [PMID: 24092986 DOI: 10.4137/IJTR.S12626] [Cited by in Crossref: 36] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
12 Kim JH, Lee YT, Hong JM, Hwang YI. Suppression of in vitro murine T cell proliferation by human adipose tissue-derived mesenchymal stem cells is dependent mainly on cyclooxygenase-2 expression. Anat Cell Biol 2013;46:262-71. [PMID: 24386599 DOI: 10.5115/acb.2013.46.4.262] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
13 Zafranskaya MM, Nizheharodova DB, Yurkevich MY, Lamouskaya NV, Motuzova YM, Bagatka SS, Ivanchik HI, Fedulov AS. In vitro assessment of mesenchymal stem cells immunosuppressive potential in multiple sclerosis patients. Immunology Letters 2013;149:9-18. [DOI: 10.1016/j.imlet.2012.10.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
14 Selmani Z, Naji A, Zidi I, Favier B, Gaiffe E, Obert L, Borg C, Saas P, Tiberghien P, Rouas-Freiss N, Carosella ED, Deschaseaux F. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. Stem Cells. 2008;26:212-222. [PMID: 17932417 DOI: 10.1634/stemcells.2007-0554] [Cited by in Crossref: 702] [Cited by in F6Publishing: 652] [Article Influence: 46.8] [Reference Citation Analysis]
15 Lönne M, Lavrentieva A, Walter J, Kasper C. Analysis of oxygen-dependent cytokine expression in human mesenchymal stem cells derived from umbilical cord. Cell Tissue Res 2013;353:117-22. [DOI: 10.1007/s00441-013-1597-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
16 Tu Z, Li Q, Bu H, Lin F. Mesenchymal stem cells inhibit complement activation by secreting factor H. Stem Cells Dev. 2010;19:1803-1809. [PMID: 20163251 DOI: 10.1089/scd.2009.0418] [Cited by in Crossref: 84] [Cited by in F6Publishing: 82] [Article Influence: 7.0] [Reference Citation Analysis]
17 Gieseke F, Böhringer J, Bussolari R, Dominici M, Handgretinger R, Müller I. Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells. Blood. 2010;116:3770-3779. [PMID: 20644118 DOI: 10.1182/blood-2010-02-270777] [Cited by in Crossref: 165] [Cited by in F6Publishing: 160] [Article Influence: 13.8] [Reference Citation Analysis]
18 Carvalho AÉS, Sousa MRR, Alencar-silva T, Carvalho JL, Saldanha-araujo F. Mesenchymal stem cells immunomodulation: The road to IFN-γ licensing and the path ahead. Cytokine & Growth Factor Reviews 2019;47:32-42. [DOI: 10.1016/j.cytogfr.2019.05.006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
19 English K, Ryan JM, Tobin L, Murphy MJ, Barry FP, Mahon BP. Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells. Clin Exp Immunol. 2009;156:149-160. [PMID: 19210524 DOI: 10.1111/j.1365-2249.2009.03874.x] [Cited by in Crossref: 475] [Cited by in F6Publishing: 438] [Article Influence: 36.5] [Reference Citation Analysis]
20 Lanz TV, Opitz CA, Ho PP, Agrawal A, Lutz C, Weller M, Mellor AL, Steinman L, Wick W, Platten M. Mouse mesenchymal stem cells suppress antigen-specific TH cell immunity independent of indoleamine 2,3-dioxygenase 1 (IDO1). Stem Cells Dev 2010;19:657-68. [PMID: 19886804 DOI: 10.1089/scd.2009.0385] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
21 Bifari F, Pacelli L, Krampera M. Immunological properties of embryonic and adult stem cells. World J Stem Cells 2010; 2(3): 50-60 [PMID: 21607122 DOI: 10.4252/wjsc.v2.i3.50] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
22 Sivanathan KN, Rojas-Canales DM, Hope CM, Krishnan R, Carroll RP, Gronthos S, Grey ST, Coates PT. Interleukin-17A-Induced Human Mesenchymal Stem Cells Are Superior Modulators of Immunological Function. Stem Cells 2015;33:2850-63. [PMID: 26037953 DOI: 10.1002/stem.2075] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 9.0] [Reference Citation Analysis]
23 Lee RH, Oh JY, Choi H, Bazhanov N. Therapeutic factors secreted by mesenchymal stromal cells and tissue repair. J Cell Biochem. 2011;112:3073-3078. [PMID: 21748781 DOI: 10.1002/jcb.23250] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 5.8] [Reference Citation Analysis]
24 Chen H, Zhang N, Li T, Guo J, Wang Z, Yang M, Gao L. Human umbilical cord Wharton’s jelly stem cells: Immune property genes assay and effect of transplantation on the immune cells of heart failure patients. Cellular Immunology 2012;276:83-90. [DOI: 10.1016/j.cellimm.2012.03.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
25 Amorin B, Alegretti AP, Valim V, Pezzi A, Laureano AM, da Silva MA, Wieck A, Silla L. Mesenchymal stem cell therapy and acute graft-versus-host disease: a review. Hum Cell 2014;27:137-50. [PMID: 24903975 DOI: 10.1007/s13577-014-0095-x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 74] [Article Influence: 9.4] [Reference Citation Analysis]
26 Najar M, Raicevic G, André T, Fayyad-Kazan H, Pieters K, Bron D, Toungouz M, Lagneaux L. Mesenchymal stromal cells from the foreskin: Tissue isolation, cell characterization and immunobiological properties. Cytotherapy 2016;18:320-35. [PMID: 26857227 DOI: 10.1016/j.jcyt.2015.11.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
27 Almeida-Porada G, Atala AJ, Porada CD. Therapeutic Mesenchymal Stromal Cells for Immunotherapy and for Gene and Drug Delivery. Mol Ther Methods Clin Dev 2020;16:204-24. [PMID: 32071924 DOI: 10.1016/j.omtm.2020.01.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
28 Holzwarth C, Vaegler M, Gieseke F, Pfister SM, Handgretinger R, Kerst G, Müller I. Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cells. BMC Cell Biol. 2010;11:11. [PMID: 20109207 DOI: 10.1186/1471-2121-11-11] [Cited by in Crossref: 205] [Cited by in F6Publishing: 191] [Article Influence: 17.1] [Reference Citation Analysis]
29 Chinnadurai R, Copland IB, Patel SR, Galipeau J. IDO-Independent Suppression of T Cell Effector Function by IFN-γ–Licensed Human Mesenchymal Stromal Cells. J I 2014;192:1491-501. [DOI: 10.4049/jimmunol.1301828] [Cited by in Crossref: 154] [Cited by in F6Publishing: 150] [Article Influence: 19.3] [Reference Citation Analysis]
30 Kim J, Lee YT, Oh K, Cho J, Lee D, Hwang Y. Paradoxical effects of human adipose tissue-derived mesenchymal stem cells on progression of experimental arthritis in SKG mice. Cellular Immunology 2014;292:94-101. [DOI: 10.1016/j.cellimm.2014.10.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
31 Zhang B, Yin Y, Lai RC, Lim SK. Immunotherapeutic potential of extracellular vesicles. Front Immunol 2014;5:518. [PMID: 25374570 DOI: 10.3389/fimmu.2014.00518] [Cited by in Crossref: 83] [Cited by in F6Publishing: 95] [Article Influence: 10.4] [Reference Citation Analysis]
32 Schäfer R, Dominici M, Müller I, Horwitz E, Asahara T, Bulte JW, Bieback K, Le Blanc K, Bühring HJ, Capogrossi MC, Dazzi F, Gorodetsky R, Henschler R, Handgretinger R, Kajstura J, Kluger PJ, Lange C, Luettichau Iv, Mertsching H, Schrezenmeier H, Sievert KD, Strunk D, Verfaillie C, Northoff H. Basic research and clinical applications of non-hematopoietic stem cells, 4-5 April 2008, Tubingen, Germany. Cytotherapy 2009;11:245-55. [PMID: 19152153 DOI: 10.1080/14653240802582117] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
33 Siegel G, Schäfer R, Dazzi F. The Immunosuppressive Properties of Mesenchymal Stem Cells. Transplantation 2009;87:S45-9. [DOI: 10.1097/tp.0b013e3181a285b0] [Cited by in Crossref: 115] [Cited by in F6Publishing: 67] [Article Influence: 8.8] [Reference Citation Analysis]
34 Iyer SS, Rojas M. Anti-inflammatory effects of mesenchymal stem cells: novel concept for future therapies. Expert Opin Biol Ther. 2008;8:569-581. [PMID: 18407762 DOI: 10.1517/14712598.8.5.569] [Cited by in Crossref: 167] [Cited by in F6Publishing: 147] [Article Influence: 11.9] [Reference Citation Analysis]
35 Dong L, Wu T, Zhang M, Gao Z, Lu D. CD3+ Cell Dose and Disease Status Are Important Factors Determining Clinical Outcomes in Patients Undergoing Unmanipulated Haploidentical Blood and Marrow Transplantation after Conditioning Including Antithymocyte Globulin. Biology of Blood and Marrow Transplantation 2007;13:1515-24. [DOI: 10.1016/j.bbmt.2007.09.007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
36 Pers YM, Jorgensen C. Mesenchymal Stromal Cells: Updates and Therapeutic Outlook in Rheumatic Diseases. J Clin Med 2013;2:201-13. [PMID: 26237144 DOI: 10.3390/jcm2040201] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
37 Kuçi Z, Seiberth J, Latifi-Pupovci H, Wehner S, Stein S, Grez M, Bönig H, Köhl U, Klingebiel T, Bader P, Kuçi S. Clonal analysis of multipotent stromal cells derived from CD271+ bone marrow mononuclear cells: functional heterogeneity and different mechanisms of allosuppression. Haematologica 2013;98:1609-16. [PMID: 23975178 DOI: 10.3324/haematol.2013.092700] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
38 Nazarov C, Lo Surdo J, Bauer SR, Wei CH. Assessment of immunosuppressive activity of human mesenchymal stem cells using murine antigen specific CD4 and CD8 T cells in vitro. Stem Cell Res Ther 2013;4:128. [PMID: 24406271 DOI: 10.1186/scrt339] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
39 Wada N, Gronthos S, Bartold PM. Immunomodulatory effects of stem cells. Periodontol 2000. 2013;63:198-216. [PMID: 23931061 DOI: 10.1111/prd.12024] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 8.4] [Reference Citation Analysis]
40 Vandermeulen M, Grégoire C, Briquet A, Lechanteur C, Beguin Y, Detry O. Rationale for the potential use of mesenchymal stromal cells in liver transplantation. World J Gastroenterol 2014; 20(44): 16418-16432 [PMID: 25469010 DOI: 10.3748/wjg.v20.i44.16418] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
41 Ghannam S, Bouffi C, Djouad F, Jorgensen C, Noël D. Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications. Stem Cell Res Ther. 2010;1:2. [PMID: 20504283 DOI: 10.1186/scrt2] [Cited by in Crossref: 318] [Cited by in F6Publishing: 302] [Article Influence: 26.5] [Reference Citation Analysis]
42 Gharibi T, Ahmadi M, Seyfizadeh N, Jadidi-Niaragh F, Yousefi M. Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of multiple sclerosis. Cell Immunol 2015;293:113-21. [PMID: 25596473 DOI: 10.1016/j.cellimm.2015.01.002] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 9.3] [Reference Citation Analysis]
43 Joo YD, Lee SM, Lee SW, Lee WS, Lee SM, Park JK, Choi IW, Park SG, Choi I, Seo SK. Granulocyte colony-stimulating factor-induced immature myeloid cells inhibit acute graft-versus-host disease lethality through an indoleamine dioxygenase-independent mechanism. Immunology 2009;128:e632-40. [PMID: 19740324 DOI: 10.1111/j.1365-2567.2009.03048.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
44 Lai RC, Yeo RW, Lim SK. Mesenchymal stem cell exosomes. Semin Cell Dev Biol. 2015;40:82-88. [PMID: 25765629 DOI: 10.1016/j.semcdb.2015.03.001] [Cited by in Crossref: 238] [Cited by in F6Publishing: 235] [Article Influence: 34.0] [Reference Citation Analysis]
45 Najar M, Lagneaux L. Foreskin as a source of immunotherapeutic mesenchymal stromal cells. Immunotherapy 2017;9:207-17. [PMID: 28128711 DOI: 10.2217/imt-2016-0093] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
46 Hao L, Sun H, Wang J, Wang T, Wang M, Zou Z. Mesenchymal stromal cells for cell therapy: besides supporting hematopoiesis. Int J Hematol. 2012;95:34-46. [PMID: 22183780 DOI: 10.1007/s12185-011-0991-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
47 Djouad F, Bouffi C, Ghannam S, Noël D, Jorgensen C. Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases. Nat Rev Rheumatol. 2009;5:392-399. [PMID: 19568253 DOI: 10.1038/nrrheum.2009.104] [Cited by in Crossref: 189] [Cited by in F6Publishing: 173] [Article Influence: 14.5] [Reference Citation Analysis]
48 Toh WS, Zhang B, Lai RC, Lim SK. Immune regulatory targets of mesenchymal stromal cell exosomes/small extracellular vesicles in tissue regeneration. Cytotherapy 2018;20:1419-26. [PMID: 30352735 DOI: 10.1016/j.jcyt.2018.09.008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
49 Naji A, Rouas-Freiss N, Durrbach A, Carosella ED, Sensébé L, Deschaseaux F. Concise review: combining human leukocyte antigen G and mesenchymal stem cells for immunosuppressant biotherapy. Stem Cells 2013;31:2296-303. [PMID: 23922260 DOI: 10.1002/stem.1494] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 4.5] [Reference Citation Analysis]
50 Ungerer C, Quade-Lyssy P, Radeke HH, Henschler R, Königs C, Köhl U, Seifried E, Schüttrumpf J. Galectin-9 is a suppressor of T and B cells and predicts the immune modulatory potential of mesenchymal stromal cell preparations. Stem Cells Dev 2014;23:755-66. [PMID: 24083426 DOI: 10.1089/scd.2013.0335] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 6.1] [Reference Citation Analysis]
51 Schäfer R, Northoff H. Characteristics of Mesenchymal Stem Cells - New Stars in Regenerative Medicine or Unrecognized Old Fellows in Autologous Regeneration? Transfus Med Hemother 2008;35:154-9. [PMID: 21547113 DOI: 10.1159/000135634] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
52 Chen PM, Yen ML, Liu KJ, Sytwu HK, Yen BL. Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells. J Biomed Sci. 2011;18:49. [PMID: 21762539 DOI: 10.1186/1423-0127-18-49] [Cited by in Crossref: 96] [Cited by in F6Publishing: 99] [Article Influence: 8.7] [Reference Citation Analysis]
53 Aleahmad M, Bozorgmehr M, Nikoo S, Ghanavatinejad A, Shokri MR, Montazeri S, Shokri F, Zarnani AH. Endometrial mesenchymal stem/stromal cells: The Enigma to code messages for generation of functionally active regulatory T cells. Stem Cell Res Ther 2021;12:536. [PMID: 34627370 DOI: 10.1186/s13287-021-02603-3] [Reference Citation Analysis]
54 Najar M, Krayem M, Merimi M, Burny A, Meuleman N, Bron D, Raicevic G, Lagneaux L. Insights into inflammatory priming of mesenchymal stromal cells: functional biological impacts. Inflamm Res. 2018;67:467-477. [PMID: 29362849 DOI: 10.1007/s00011-018-1131-1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 9.3] [Reference Citation Analysis]
55 Heldring N, Mäger I, Wood MJ, Le Blanc K, Andaloussi SE. Therapeutic Potential of Multipotent Mesenchymal Stromal Cells and Their Extracellular Vesicles. Hum Gene Ther 2015;26:506-17. [PMID: 26153722 DOI: 10.1089/hum.2015.072] [Cited by in Crossref: 89] [Cited by in F6Publishing: 84] [Article Influence: 12.7] [Reference Citation Analysis]
56 Bach LA. What Happened to the IGF Binding Proteins? Endocrinology 2018;159:570-8. [PMID: 29165552 DOI: 10.1210/en.2017-00908] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
57 Bifari F, Lisi V, Mimiola E, Pasini A, Krampera M. Immune Modulation by Mesenchymal Stem Cells. Transfus Med Hemother. 2008;35:194-204. [PMID: 21547117 DOI: 10.1159/000128968] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
58 Dong R, Liu Y, Yang Y, Wang H, Xu Y, Zhang Z. MSC-Derived Exosomes-Based Therapy for Peripheral Nerve Injury: A Novel Therapeutic Strategy. Biomed Res Int. 2019;2019:6458237. [PMID: 31531362 DOI: 10.1155/2019/6458237] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
59 Liao Y, Lei J, Liu M, Lin W, Hong D, Tuo Y, Jiang MH, Xia H, Wang M, Huang W, Xiang AP. Mesenchymal Stromal Cells Mitigate Experimental Colitis via Insulin-like Growth Factor Binding Protein 7-mediated Immunosuppression. Mol Ther 2016;24:1860-72. [PMID: 27397633 DOI: 10.1038/mt.2016.140] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
60 Popp FC, Eggenhofer E, Renner P, Geissler EK, Piso P, Schlitt HJ, Dahlke MH. Mesenchymal stem cells can affect solid organ allograft survival. Transplantation 2009;87:S57-62. [PMID: 19424009 DOI: 10.1097/TP.0b013e3181a288aa] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
61 Haniffa MA, Collin MP, Buckley CD, Dazzi F. Mesenchymal stem cells: the fibroblasts' new clothes? Haematologica 2009;94:258-63. [PMID: 19109217 DOI: 10.3324/haematol.13699] [Cited by in Crossref: 239] [Cited by in F6Publishing: 217] [Article Influence: 17.1] [Reference Citation Analysis]
62 Najar M, Raicevic G, Fayyad-Kazan H, De Bruyn C, Bron D, Toungouz M, Lagneaux L. Immune-related antigens, surface molecules and regulatory factors in human-derived mesenchymal stromal cells: the expression and impact of inflammatory priming. Stem Cell Rev Rep. 2012;8:1188-1198. [PMID: 22983809 DOI: 10.1007/s12015-012-9408-1] [Cited by in Crossref: 83] [Cited by in F6Publishing: 81] [Article Influence: 9.2] [Reference Citation Analysis]
63 Donofrio G, Taddei S, Franceschi V, Capocefalo A, Cavirani S, Martinelli N, Ottonello S, Ferrari M. Swine adipose stromal cells loaded with recombinant bovine herpesvirus 4 virions expressing a foreign antigen induce potent humoral immune responses in pigs. Vaccine 2011;29:867-72. [PMID: 21115049 DOI: 10.1016/j.vaccine.2010.11.048] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
64 Ding Y, Xu D, Feng G, Bushell A, Muschel RJ, Wood KJ. Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9. Diabetes. 2009;58:1797-1806. [PMID: 19509016 DOI: 10.2337/db09-0317] [Cited by in Crossref: 210] [Cited by in F6Publishing: 184] [Article Influence: 16.2] [Reference Citation Analysis]
65 Torres Crigna A, Uhlig S, Elvers-Hornung S, Klüter H, Bieback K. Human Adipose Tissue-Derived Stromal Cells Suppress Human, but Not Murine Lymphocyte Proliferation, via Indoleamine 2,3-Dioxygenase Activity. Cells 2020;9:E2419. [PMID: 33167329 DOI: 10.3390/cells9112419] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
66 Yang C, Zheng C, Lin H, Li J, Zhao K. Role of Suppressor of Cytokine Signaling 3 in the Immune Modulation of Mesenchymal Stromal Cells. Inflammation 2016;39:257-68. [PMID: 26318865 DOI: 10.1007/s10753-015-0246-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
67 García-Gómez I, Elvira G, Zapata AG, Lamana ML, Ramírez M, Castro JG, Arranz MG, Vicente A, Bueren J, García-Olmo D. Mesenchymal stem cells: biological properties and clinical applications. Expert Opin Biol Ther. 2010;10:1453-1468. [PMID: 20831449 DOI: 10.1517/14712598.2010.519333] [Cited by in Crossref: 105] [Cited by in F6Publishing: 104] [Article Influence: 9.5] [Reference Citation Analysis]